‘Global Artificial Intelligence in Healthcare Market By Component (Hardware, Software, Service, By Technology (Querying Method, Natural Language Processing, Context Aware Processing, Speech Recognition, Decision Management, Others (Biometrics, AI Modeling, Etc.)), By Application (Robot assisted Surgery, Virtual Nursing Assistants, Administrative Workflow Assistance, Fraud Detection, Connected Machines, Clinical Trails, Preliminary Diagnosis, Others (Dosage Error Reduction, Cybersecurity, Etc.), By End Users (Healthcare Providers, Pharmaceutical & Biotechnology Company, Patient, Payer), By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, The Benelux Union, Rest of Europe, China, Japan, India, Australia, New Zealand, Southeast Asia, Rest of Asia Pacific, GCC Countries, Southern Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 – 2027’

Report ID :AMI-170 | Category : Information And Communication Technology | Published Date : February, 2019 | Pages : 521 | Format :PDF
Buy Now!

Industry Trends:

Artificial intelligence is being significantly used for a range of healthcare & research purposes which finely consists of disease detection, healthcare delivery services, drug discovery and chronic condition management. It has been reported that as the geriatric population is increasing in some economies (such as the United Kingdom), the need for better access and quality of care is necessary for population aged over 100. Thus, the adoption of virtual health coaches & nurses along with AI- based clinical services for diagnosing illnesses at home is expected to proliferate the healthcare industry.

IBM Watson Care Manager System matches individuals with a care provider that meets their needs and is within their allocated care budget. The company aims to design individual care plans and offers insights for more effective use of care management resources. Alder Hey Children’s Hospital based in Liverpool is working with IBM Watson to create a “cognitive hospital”. This will include an app that will facilitate interactions with patients. This application usage is designed for identifying patient anxieties before a visit and helping clinicians to deliver proper treatment services to the targeted individuals.

AI is used to identify and analyze patterns faster and precisely in large complex datasets.  The Institute of Cancer Research’s canSAR database duly combines clinical & genetic data from patients with information derived from scientific research. They use artificial intelligence technology to make predictions about the new discoveries about the cancer drugs. The development of “Eve”, an AI robot scientist by researchers enables the drug discovery processes to be both faster and economical in nature. The possible use of AI in clinical care includes medical imaging, echocardiography, screening for neurological conditions and surgery. Taking echocardiography as an instance, the Ultromics system, trialed at John Radcliffe Hospital used AI application for analyzing echocardiography scans, mainly for detecting heartbeat patterns and diagnose coronary heart disease. Robotic AI tools were used to carry out specific tasks in keyhole surgery that included tying knots to close wounds.

Global artificial intelligence in healthcare market is expanding at a CAGR of 48.29 % over the forecast period. The study analyzes the market in terms of revenue, production and sales volume across all the major markets.

North America Artificial Intelligence in Healthcare Market Sales, 2019 - 2027

Global Artificial Intelligence in Healthcare Market

Competitive Landscape

The report provides both, qualitative and quantitative research of global artificial intelligence in healthcare market, as well as provides worthy insights into the rational scenario and favored development methods adopted by key contenders. The report also offers extensive research on the key players in global artificial intelligence in healthcare market and detailed insights on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes their headquarter, competitors, product/service type, application and specification, pricing, and gross margin.

Market participants include Bay Labs, Inc, CloudMedx Inc., Enclitic, General Electric, General Vision, Google Inc., IBM Corporation, iCarbonX, Intel Corporation, Koninklijke Philips, maxQ, Microsoft, Next IT Corp., Nvidia Corporation, Siemens Healthcare GmbH, Welltok amongst others

By Component

  • Hardware
  • Software
  • Service

By Technology 

  • Querying Method
  • Natural Language Processing
  • Context Aware Processing
  • Speech Recognition
  • Decision Management
  • Others (Biometrics, AI Modeling, Etc.)

By Application 

  • Robot assisted Surgery
  • Virtual Nursing Assistants
  • Administrative Workflow Assistance
  • Fraud Detection, Connected Machines
  • Clinical Trails
  • Preliminary Diagnosis
  • Others (Dosage Error Reduction, Cybersecurity, Etc.),

By End Users 

  • Healthcare Providers
  • Pharmaceutical & Biotechnology Company
  • Patient
  • Payer

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Key Questions

Request Sample

Report Customization

Request for Customization

Table of Contents

 


1.    Market Scope

1.1.   Market Segmentation

1.2.   Years Considered

1.2.1.   Historic Years: 2013 - 2017

1.2.2.   Base Year: 2018

1.2.3.   Forecast Years: 2019 – 2027

2.    Key Target Audiences

3.    Research Methodology

3.1.   Primary Research

3.1.1.   Research Questionnaire

3.1.2.   Country-Wise Percentage Breakdown

3.1.3.   Primary Interviews: Key Opinion Leaders (KOLs)

3.2.   Secondary Research

3.2.1.   Paid Databases

3.2.2.   Secondary Sources

3.3.   Market Size Estimates

3.3.1.   Top-Down Approach

3.3.2.   Bottom-Up Approach

3.4.   Data Triangulation Methodology

3.5.   Research Assumptions

4.    Recommendations and Insights from AMI’s Perspective**

5.    Holistic Overview of Artificial Intelligence in Healthcare Market

6.    Market Synopsis:  Artificial Intelligence in Healthcare Market

7.    Artificial Intelligence in Healthcare Market Analysis: Qualitative Perspective

7.1.   Introduction

7.1.1.   Product Definition

7.1.2.   Industry Development

7.2.   Market Dynamics

7.2.1.   Drivers

7.2.2.   Restraints

7.2.3.   Opportunities

7.2.4.   Challenges

7.3.   Trends in Artificial Intelligence in Healthcare Market

7.4.   Market Determinants Radar Chart

7.5.   Porter’s Five Force Analysis

7.6.   SWOT Analysis

8.    Global Artificial Intelligence in Medicine Market Analysis and Forecasts, 2019 – 2027

8.1.   Overview

8.1.1.   Global Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts

8.2.   Global Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

8.2.1.   Hardware

8.2.1.1.    Definition

8.2.1.2.    Market Penetration, 2018

8.2.1.3.    Market Estimation, 2013 – 2018

8.2.1.4.    Market Forecast, 2019 – 2027

8.2.1.5.    Compound Annual Growth Rate (CAGR)

8.2.1.6.    Regional Bifurcation

8.2.1.6.1.    North America

8.2.1.6.1.1.  Market Estimation, 2013 – 2018

8.2.1.6.1.2.  Market Forecast, 2019 – 2027

8.2.1.6.2.    Europe

8.2.1.6.2.1.  Market Estimation, 2013 – 2018

8.2.1.6.2.2.  Market Forecast, 2019 – 2027

8.2.1.6.3.    Asia Pacific

8.2.1.6.3.1.  Market Estimation, 2013 – 2018

8.2.1.6.3.2.  Market Forecast, 2019 – 2027

8.2.1.6.4.    Middle East and Africa

8.2.1.6.4.1.  Market Estimation, 2013 – 2018

8.2.1.6.4.2.  Market Forecast, 2019 – 2027

8.2.1.6.5.    Latin America

8.2.1.6.5.1.  Market Estimation, 2013 – 2018

8.2.1.6.5.2.  Market Forecast, 2019 – 2027

8.2.2.   Software

8.2.2.1.    Definition

8.2.2.2.    Market Penetration, 2018

8.2.2.3.    Market Estimation, 2013 – 2018

8.2.2.4.    Market Forecast, 2019 – 2027

8.2.2.5.    Compound Annual Growth Rate (CAGR)

8.2.2.6.    Regional Bifurcation

8.2.2.6.1.    North America

8.2.2.6.1.1.  Market Estimation, 2013 – 2018

8.2.2.6.1.2.  Market Forecast, 2019 – 2027

8.2.2.6.2.    Europe

8.2.2.6.2.1.  Market Estimation, 2013 – 2018

8.2.2.6.2.2.  Market Forecast, 2019 – 2027

8.2.2.6.3.    Asia Pacific

8.2.2.6.3.1.  Market Estimation, 2013 – 2018

8.2.2.6.3.2.  Market Forecast, 2019 – 2027

8.2.2.6.4.    Middle East and Africa

8.2.2.6.4.1.  Market Estimation, 2013 – 2018

8.2.2.6.4.2.  Market Forecast, 2019 – 2027

8.2.2.6.5.    Latin America

8.2.2.6.5.1.  Market Estimation, 2013 – 2018

8.2.2.6.5.2.  Market Forecast, 2019 – 2027

8.2.3.   Service

8.2.3.1.    Definition

8.2.3.2.    Market Penetration, 2018

8.2.3.3.    Market Estimation, 2013 – 2018

8.2.3.4.    Market Forecast, 2019 – 2027

8.2.3.5.    Compound Annual Growth Rate (CAGR)

8.2.3.6.    Regional Bifurcation

8.2.3.6.1.    North America

8.2.3.6.1.1.  Market Estimation, 2013 – 2018

8.2.3.6.1.2.  Market Forecast, 2019 – 2027

8.2.3.6.2.    Europe

8.2.3.6.2.1.  Market Estimation, 2013 – 2018

8.2.3.6.2.2.  Market Forecast, 2019 – 2027

8.2.3.6.3.    Asia Pacific

8.2.3.6.3.1.  Market Estimation, 2013 – 2018

8.2.3.6.3.2.  Market Forecast, 2019 – 2027

8.2.3.6.4.    Middle East and Africa

8.2.3.6.4.1.  Market Estimation, 2013 – 2018

8.2.3.6.4.2.  Market Forecast, 2019 – 2027

8.2.3.6.5.    Latin America

8.2.3.6.5.1.  Market Estimation, 2013 – 2018

8.2.3.6.5.2.  Market Forecast, 2019 – 2027

8.3.   Key Segment for Channeling Investments

8.3.1.   By Component

9.    Global Artificial Intelligence in Medicine Market Analysis and Forecasts, 2019 – 2027

9.1.   Overview

9.2.   Global Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

9.2.1.   Querying Method

9.2.1.1.    Definition

9.2.1.2.    Market Penetration, 2018

9.2.1.3.    Market Estimation, 2013 – 2018

9.2.1.4.    Market Forecast, 2019 – 2027

9.2.1.5.    Compound Annual Growth Rate (CAGR)

9.2.1.6.    Regional Bifurcation

9.2.1.6.1.    North America

9.2.1.6.1.1.  Market Estimation, 2013 – 2018

9.2.1.6.1.2.  Market Forecast, 2019 – 2027

9.2.1.6.2.    Europe

9.2.1.6.2.1.  Market Estimation, 2013 – 2018

9.2.1.6.2.2.  Market Forecast, 2019 – 2027

9.2.1.6.3.    Asia Pacific

9.2.1.6.3.1.  Market Estimation, 2013 – 2018

9.2.1.6.3.2.  Market Forecast, 2019 – 2027

9.2.1.6.4.    Middle East and Africa

9.2.1.6.4.1.  Market Estimation, 2013 – 2018

9.2.1.6.4.2.  Market Forecast, 2019 – 2027

9.2.1.6.5.    Latin America

9.2.1.6.5.1.  Market Estimation, 2013 – 2018

9.2.1.6.5.2.  Market Forecast, 2019 – 2027

9.2.2.   Natural Language Processing

9.2.2.1.    Definition

9.2.2.2.    Market Penetration, 2018

9.2.2.3.    Market Estimation, 2013 – 2018

9.2.2.4.    Market Forecast, 2019 – 2027

9.2.2.5.    Compound Annual Growth Rate (CAGR)

9.2.2.6.    Regional Bifurcation

9.2.2.6.1.    North America

9.2.2.6.1.1.  Market Estimation, 2013 – 2018

9.2.2.6.1.2.  Market Forecast, 2019 – 2027

9.2.2.6.2.    Europe

9.2.2.6.2.1.  Market Estimation, 2013 – 2018

9.2.2.6.2.2.  Market Forecast, 2019 – 2027

9.2.2.6.3.    Asia Pacific

9.2.2.6.3.1.  Market Estimation, 2013 – 2018

9.2.2.6.3.2.  Market Forecast, 2019 – 2027

9.2.2.6.4.    Middle East and Africa

9.2.2.6.4.1.  Market Estimation, 2013 – 2018

9.2.2.6.4.2.  Market Forecast, 2019 – 2027

9.2.2.6.5.    Latin America

9.2.2.6.5.1.  Market Estimation, 2013 – 2018

9.2.2.6.5.2.  Market Forecast, 2019 – 2027

9.2.3.   Context Aware Processing

9.2.3.1.    Definition

9.2.3.2.    Market Penetration, 2018

9.2.3.3.    Market Estimation, 2013 – 2018

9.2.3.4.    Market Forecast, 2019 – 2027

9.2.3.5.    Compound Annual Growth Rate (CAGR)

9.2.3.6.    Regional Bifurcation

9.2.3.6.1.    North America

9.2.3.6.1.1.  Market Estimation, 2013 – 2018

9.2.3.6.1.2.  Market Forecast, 2019 – 2027

9.2.3.6.2.    Europe

9.2.3.6.2.1.  Market Estimation, 2013 – 2018

9.2.3.6.2.2.  Market Forecast, 2019 – 2027

9.2.3.6.3.    Asia Pacific

9.2.3.6.3.1.  Market Estimation, 2013 – 2018

9.2.3.6.3.2.  Market Forecast, 2019 – 2027

9.2.3.6.4.    Middle East and Africa

9.2.3.6.4.1.  Market Estimation, 2013 – 2018

9.2.3.6.4.2.  Market Forecast, 2019 – 2027

9.2.3.6.5.    Latin America

9.2.3.6.5.1.  Market Estimation, 2013 – 2018

9.2.3.6.5.2.  Market Forecast, 2019 – 2027

9.2.4.   Speech Recognition

9.2.4.1.    Definition

9.2.4.2.    Market Penetration, 2018

9.2.4.3.    Market Estimation, 2013 – 2018

9.2.4.4.    Market Forecast, 2019 – 2027

9.2.4.5.    Compound Annual Growth Rate (CAGR)

9.2.4.6.    Regional Bifurcation

9.2.4.6.1.    North America

9.2.4.6.1.1.  Market Estimation, 2013 – 2018

9.2.4.6.1.2.  Market Forecast, 2019 – 2027

9.2.4.6.2.    Europe

9.2.4.6.2.1.  Market Estimation, 2013 – 2018

9.2.4.6.2.2.  Market Forecast, 2019 – 2027

9.2.4.6.3.    Asia Pacific

9.2.4.6.3.1.  Market Estimation, 2013 – 2018

9.2.4.6.3.2.  Market Forecast, 2019 – 2027

9.2.4.6.4.    Middle East and Africa

9.2.4.6.4.1.  Market Estimation, 2013 – 2018

9.2.4.6.4.2.  Market Forecast, 2019 – 2027

9.2.4.6.5.    Latin America

9.2.4.6.5.1.  Market Estimation, 2013 – 2018

9.2.4.6.5.2.  Market Forecast, 2019 – 2027

9.2.5.   Decision Management

9.2.5.1.    Definition

9.2.5.2.    Market Penetration, 2018

9.2.5.3.    Market Estimation, 2013 – 2018

9.2.5.4.    Market Forecast, 2019 – 2027

9.2.5.5.    Compound Annual Growth Rate (CAGR)

9.2.5.6.    Regional Bifurcation

9.2.5.6.1.    North America

9.2.5.6.1.1.  Market Estimation, 2013 – 2018

9.2.5.6.1.2.  Market Forecast, 2019 – 2027

9.2.5.6.2.    Europe

9.2.5.6.2.1.  Market Estimation, 2013 – 2018

9.2.5.6.2.2.  Market Forecast, 2019 – 2027

9.2.5.6.3.    Asia Pacific

9.2.5.6.3.1.  Market Estimation, 2013 – 2018

9.2.5.6.3.2.  Market Forecast, 2019 – 2027

9.2.5.6.4.    Middle East and Africa

9.2.5.6.4.1.  Market Estimation, 2013 – 2018

9.2.5.6.4.2.  Market Forecast, 2019 – 2027

9.2.5.6.5.    Latin America

9.2.5.6.5.1.  Market Estimation, 2013 – 2018

9.2.5.6.5.2.  Market Forecast, 2019 – 2027

9.2.6.   Others (Biometrics, AI Modeling, Etc.)

9.2.6.1.    Definition

9.2.6.2.    Market Penetration, 2018

9.2.6.3.    Market Estimation, 2013 – 2018

9.2.6.4.    Market Forecast, 2019 – 2027

9.2.6.5.    Compound Annual Growth Rate (CAGR)

9.2.6.6.    Regional Bifurcation

9.2.6.6.1.    North America

9.2.6.6.1.1.  Market Estimation, 2013 – 2018

9.2.6.6.1.2.  Market Forecast, 2019 – 2027

9.2.6.6.2.    Europe

9.2.6.6.2.1.  Market Estimation, 2013 – 2018

9.2.6.6.2.2.  Market Forecast, 2019 – 2027

9.2.6.6.3.    Asia Pacific

9.2.6.6.3.1.  Market Estimation, 2013 – 2018

9.2.6.6.3.2.  Market Forecast, 2019 – 2027

9.2.6.6.4.    Middle East and Africa

9.2.6.6.4.1.  Market Estimation, 2013 – 2018

9.2.6.6.4.2.  Market Forecast, 2019 – 2027

9.2.6.6.5.    Latin America

9.2.6.6.5.1.  Market Estimation, 2013 – 2018

9.2.6.6.5.2.  Market Forecast, 2019 – 2027

9.3.   Key Segment for Channeling Investments

9.3.1.   By Technology

10. Global Artificial Intelligence in Medicine Market Analysis and Forecasts, 2019 – 2027

10.1. Overview

10.2. Global Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

10.2.1. Robot Assisted Surgery

10.2.1.1.  Definition

10.2.1.2.  Market Penetration, 2018

10.2.1.3.  Market Estimation, 2013 – 2018

10.2.1.4.  Market Forecast, 2019 – 2027

10.2.1.5.  Compound Annual Growth Rate (CAGR)

10.2.1.6.  Regional Bifurcation

10.2.1.6.1.  North America

10.2.1.6.1.1.  Market Estimation, 2013 – 2018

10.2.1.6.1.2.  Market Forecast, 2019 – 2027

10.2.1.6.2.  Europe

10.2.1.6.2.1.  Market Estimation, 2013 – 2018

10.2.1.6.2.2.  Market Forecast, 2019 – 2027

10.2.1.6.3.  Asia Pacific

10.2.1.6.3.1.  Market Estimation, 2013 – 2018

10.2.1.6.3.2.  Market Forecast, 2019 – 2027

10.2.1.6.4.  Middle East and Africa

10.2.1.6.4.1.  Market Estimation, 2013 – 2018

10.2.1.6.4.2.  Market Forecast, 2019 – 2027

10.2.1.6.5.  Latin America

10.2.1.6.5.1.  Market Estimation, 2013 – 2018

10.2.1.6.5.2.  Market Forecast, 2019 – 2027

10.2.2. Virtual Nursing Assistants

10.2.2.1.  Definition

10.2.2.2.  Market Penetration, 2018

10.2.2.3.  Market Estimation, 2013 – 2018

10.2.2.4.  Market Forecast, 2019 – 2027

10.2.2.5.  Compound Annual Growth Rate (CAGR)

10.2.2.6.  Regional Bifurcation

10.2.2.6.1.  North America

10.2.2.6.1.1.  Market Estimation, 2013 – 2018

10.2.2.6.1.2.  Market Forecast, 2019 – 2027

10.2.2.6.2.  Europe

10.2.2.6.2.1.  Market Estimation, 2013 – 2018

10.2.2.6.2.2.  Market Forecast, 2019 – 2027

10.2.2.6.3.  Asia Pacific

10.2.2.6.3.1.  Market Estimation, 2013 – 2018

10.2.2.6.3.2.  Market Forecast, 2019 – 2027

10.2.2.6.4.  Middle East and Africa

10.2.2.6.4.1.  Market Estimation, 2013 – 2018

10.2.2.6.4.2.  Market Forecast, 2019 – 2027

10.2.2.6.5.  Latin America

10.2.2.6.5.1.  Market Estimation, 2013 – 2018

10.2.2.6.5.2.  Market Forecast, 2019 – 2027

10.2.3. Administrative Workflow Assistance

10.2.3.1.  Definition

10.2.3.2.  Market Penetration, 2018

10.2.3.3.  Market Estimation, 2013 – 2018

10.2.3.4.  Market Forecast, 2019 – 2027

10.2.3.5.  Compound Annual Growth Rate (CAGR)

10.2.3.6.  Regional Bifurcation

10.2.3.6.1.  North America

10.2.3.6.1.1.  Market Estimation, 2013 – 2018

10.2.3.6.1.2.  Market Forecast, 2019 – 2027

10.2.3.6.2.  Europe

10.2.3.6.2.1.  Market Estimation, 2013 – 2018

10.2.3.6.2.2.  Market Forecast, 2019 – 2027

10.2.3.6.3.  Asia Pacific

10.2.3.6.3.1.  Market Estimation, 2013 – 2018

10.2.3.6.3.2.  Market Forecast, 2019 – 2027

10.2.3.6.4.  Middle East and Africa

10.2.3.6.4.1.  Market Estimation, 2013 – 2018

10.2.3.6.4.2.  Market Forecast, 2019 – 2027

10.2.3.6.5.  Latin America

10.2.3.6.5.1.  Market Estimation, 2013 – 2018

10.2.3.6.5.2.  Market Forecast, 2019 – 2027

10.2.4. Fraud Detection

10.2.4.1.  Definition

10.2.4.2.  Market Penetration, 2018

10.2.4.3.  Market Estimation, 2013 – 2018

10.2.4.4.  Market Forecast, 2019 – 2027

10.2.4.5.  Compound Annual Growth Rate (CAGR)

10.2.4.6.  Regional Bifurcation

10.2.4.6.1.  North America

10.2.4.6.1.1.  Market Estimation, 2013 – 2018

10.2.4.6.1.2.  Market Forecast, 2019 – 2027

10.2.4.6.2.  Europe

10.2.4.6.2.1.  Market Estimation, 2013 – 2018

10.2.4.6.2.2.  Market Forecast, 2019 – 2027

10.2.4.6.3.  Asia Pacific

10.2.4.6.3.1.  Market Estimation, 2013 – 2018

10.2.4.6.3.2.  Market Forecast, 2019 – 2027

10.2.4.6.4.  Middle East and Africa

10.2.4.6.4.1.  Market Estimation, 2013 – 2018

10.2.4.6.4.2.  Market Forecast, 2019 – 2027

10.2.4.6.5.  Latin America

10.2.4.6.5.1.  Market Estimation, 2013 – 2018

10.2.4.6.5.2.  Market Forecast, 2019 – 2027

10.2.5. Connected Machines

10.2.5.1.  Definition

10.2.5.2.  Market Penetration, 2018

10.2.5.3.  Market Estimation, 2013 – 2018

10.2.5.4.  Market Forecast, 2019 – 2027

10.2.5.5.  Compound Annual Growth Rate (CAGR)

10.2.5.6.  Regional Bifurcation

10.2.5.6.1.  North America

10.2.5.6.1.1.  Market Estimation, 2013 – 2018

10.2.5.6.1.2.  Market Forecast, 2019 – 2027

10.2.5.6.2.  Europe

10.2.5.6.2.1.  Market Estimation, 2013 – 2018

10.2.5.6.2.2.  Market Forecast, 2019 – 2027

10.2.5.6.3.  Asia Pacific

10.2.5.6.3.1.  Market Estimation, 2013 – 2018

10.2.5.6.3.2.  Market Forecast, 2019 – 2027

10.2.5.6.4.  Middle East and Africa

10.2.5.6.4.1.  Market Estimation, 2013 – 2018

10.2.5.6.4.2.  Market Forecast, 2019 – 2027

10.2.5.6.5.  Latin America

10.2.5.6.5.1.  Market Estimation, 2013 – 2018

10.2.5.6.5.2.  Market Forecast, 2019 – 2027

10.2.6. Clinical Trial

10.2.6.1.  Definition

10.2.6.2.  Market Penetration, 2018

10.2.6.3.  Market Estimation, 2013 – 2018

10.2.6.4.  Market Forecast, 2019 – 2027

10.2.6.5.  Compound Annual Growth Rate (CAGR)

10.2.6.6.  Regional Bifurcation

10.2.6.6.1.  North America

10.2.6.6.1.1.  Market Estimation, 2013 – 2018

10.2.6.6.1.2.  Market Forecast, 2019 – 2027

10.2.6.6.2.  Europe

10.2.6.6.2.1.  Market Estimation, 2013 – 2018

10.2.6.6.2.2.  Market Forecast, 2019 – 2027

10.2.6.6.3.  Asia Pacific

10.2.6.6.3.1.  Market Estimation, 2013 – 2018

10.2.6.6.3.2.  Market Forecast, 2019 – 2027

10.2.6.6.4.  Middle East and Africa

10.2.6.6.4.1.  Market Estimation, 2013 – 2018

10.2.6.6.4.2.  Market Forecast, 2019 – 2027

10.2.6.6.5.  Latin America

10.2.6.6.5.1.  Market Estimation, 2013 – 2018

10.2.6.6.5.2.  Market Forecast, 2019 – 2027

10.2.7. Preliminary Diagnosis

10.2.7.1.  Definition

10.2.7.2.  Market Penetration, 2018

10.2.7.3.  Market Estimation, 2013 – 2018

10.2.7.4.  Market Forecast, 2019 – 2027

10.2.7.5.  Compound Annual Growth Rate (CAGR)

10.2.7.6.  Regional Bifurcation

10.2.7.6.1.  North America

10.2.7.6.1.1.  Market Estimation, 2013 – 2018

10.2.7.6.1.2.  Market Forecast, 2019 – 2027

10.2.7.6.2.  Europe

10.2.7.6.2.1.  Market Estimation, 2013 – 2018

10.2.7.6.2.2.  Market Forecast, 2019 – 2027

10.2.7.6.3.  Asia Pacific

10.2.7.6.3.1.    Market Estimation, 2013 – 2018

10.2.7.6.3.2.    Market Forecast, 2019 – 2027

10.2.7.6.4.  Middle East and Africa

10.2.7.6.4.1.    Market Estimation, 2013 – 2018

10.2.7.6.4.2.    Market Forecast, 2019 – 2027

10.2.7.6.5.  Latin America

10.2.7.6.5.1.    Market Estimation, 2013 – 2018

10.2.7.6.5.2.    Market Forecast, 2019 – 2027

10.2.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)

10.2.8.1.  Definition

10.2.8.2.  Market Penetration, 2018

10.2.8.3.  Market Estimation, 2013 – 2018

10.2.8.4.  Market Forecast, 2019 – 2027

10.2.8.5.  Compound Annual Growth Rate (CAGR)

10.2.8.6.  Regional Bifurcation

10.2.8.6.1.  North America

10.2.8.6.1.1.    Market Estimation, 2013 – 2018

10.2.8.6.1.2.    Market Forecast, 2019 – 2027

10.2.8.6.2.  Europe

10.2.8.6.2.1.    Market Estimation, 2013 – 2018

10.2.8.6.2.2.    Market Forecast, 2019 – 2027

10.2.8.6.3.  Asia Pacific

10.2.8.6.3.1.    Market Estimation, 2013 – 2018

10.2.8.6.3.2.    Market Forecast, 2019 – 2027

10.2.8.6.4.  Middle East and Africa

10.2.8.6.4.1.    Market Estimation, 2013 – 2018

10.2.8.6.4.2.    Market Forecast, 2019 – 2027

10.2.8.6.5.  Latin America

10.2.8.6.5.1.    Market Estimation, 2013 – 2018

10.2.8.6.5.2.    Market Forecast, 2019 – 2027

10.3. Key Segment for Channeling Investments

10.3.1. By Application

11. Global Artificial Intelligence in Medicine Market Analysis and Forecasts, 2019 – 2027

11.1. Overview

11.2. Global Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

11.2.1. Healthcare Providers

11.2.1.1.  Definition

11.2.1.2.  Market Penetration, 2018

11.2.1.3.  Market Estimation, 2013 – 2018

11.2.1.4.  Market Forecast, 2019 – 2027

11.2.1.5.  Compound Annual Growth Rate (CAGR)

11.2.1.6.  Regional Bifurcation

11.2.1.6.1.  North America

11.2.1.6.1.1.    Market Estimation, 2013 – 2018

11.2.1.6.1.2.    Market Forecast, 2019 – 2027

11.2.1.6.2.  Europe

11.2.1.6.2.1.    Market Estimation, 2013 – 2018

11.2.1.6.2.2.    Market Forecast, 2019 – 2027

11.2.1.6.3.  Asia Pacific

11.2.1.6.3.1.    Market Estimation, 2013 – 2018

11.2.1.6.3.2.    Market Forecast, 2019 – 2027

11.2.1.6.4.  Middle East and Africa

11.2.1.6.4.1.    Market Estimation, 2013 – 2018

11.2.1.6.4.2.    Market Forecast, 2019 – 2027

11.2.1.6.5.  Latin America

11.2.1.6.5.1.    Market Estimation, 2013 – 2018

11.2.1.6.5.2.    Market Forecast, 2019 – 2027

11.2.2. Pharmaceutical & Biotechnology Company

11.2.2.1.  Definition

11.2.2.2.  Market Penetration, 2018

11.2.2.3.  Market Estimation, 2013 – 2018

11.2.2.4.  Market Forecast, 2019 – 2027

11.2.2.5.  Compound Annual Growth Rate (CAGR)

11.2.2.6.  Regional Bifurcation

11.2.2.6.1.  North America

11.2.2.6.1.1.    Market Estimation, 2013 – 2018

11.2.2.6.1.2.    Market Forecast, 2019 – 2027

11.2.2.6.2.  Europe

11.2.2.6.2.1.    Market Estimation, 2013 – 2018

11.2.2.6.2.2.    Market Forecast, 2019 – 2027

11.2.2.6.3.  Asia Pacific

11.2.2.6.3.1.    Market Estimation, 2013 – 2018

11.2.2.6.3.2.    Market Forecast, 2019 – 2027

11.2.2.6.4.  Middle East and Africa

11.2.2.6.4.1.    Market Estimation, 2013 – 2018

11.2.2.6.4.2.    Market Forecast, 2019 – 2027

11.2.2.6.5.  Latin America

11.2.2.6.5.1.    Market Estimation, 2013 – 2018

11.2.2.6.5.2.    Market Forecast, 2019 – 2027

11.2.3.  Patient

11.2.3.1.  Definition

11.2.3.2.  Market Penetration, 2018

11.2.3.3.  Market Estimation, 2013 – 2018

11.2.3.4.  Market Forecast, 2019 – 2027

11.2.3.5.  Compound Annual Growth Rate (CAGR)

11.2.3.6.  Regional Bifurcation

11.2.3.6.1.  North America

11.2.3.6.1.1.    Market Estimation, 2013 – 2018

11.2.3.6.1.2.    Market Forecast, 2019 – 2027

11.2.3.6.2.  Europe

11.2.3.6.2.1.    Market Estimation, 2013 – 2018

11.2.3.6.2.2.    Market Forecast, 2019 – 2027

11.2.3.6.3.  Asia Pacific

11.2.3.6.3.1.    Market Estimation, 2013 – 2018

11.2.3.6.3.2.    Market Forecast, 2019 – 2027

11.2.3.6.4.  Middle East and Africa

11.2.3.6.4.1.    Market Estimation, 2013 – 2018

11.2.3.6.4.2.    Market Forecast, 2019 – 2027

11.2.3.6.5.  Latin America

11.2.3.6.5.1.    Market Estimation, 2013 – 2018

11.2.3.6.5.2.    Market Forecast, 2019 – 2027

11.2.4. Payer

11.2.4.1.  Definition

11.2.4.2.  Market Penetration, 2018

11.2.4.3.  Market Estimation, 2013 – 2018

11.2.4.4.  Market Forecast, 2019 – 2027

11.2.4.5.  Compound Annual Growth Rate (CAGR)

11.2.4.6.  Regional Bifurcation

11.2.4.6.1.  North America

11.2.4.6.1.1.    Market Estimation, 2013 – 2018

11.2.4.6.1.2.    Market Forecast, 2019 – 2027

11.2.4.6.2.  Europe

11.2.4.6.2.1.    Market Estimation, 2013 – 2018

11.2.4.6.2.2.    Market Forecast, 2019 – 2027

11.2.4.6.3.  Asia Pacific

11.2.4.6.3.1.    Market Estimation, 2013 – 2018

11.2.4.6.3.2.    Market Forecast, 2019 – 2027

11.2.4.6.4.  Middle East and Africa

11.2.4.6.4.1.    Market Estimation, 2013 – 2018

11.2.4.6.4.2.    Market Forecast, 2019 – 2027

11.2.4.6.5.  Latin America

11.2.4.6.5.1.    Market Estimation, 2013 – 2018

11.2.4.6.5.2.    Market Forecast, 2019 – 2027

11.3. Key Segment for Channeling Investments

11.3.1. By End Users

12. North America Artificial Intelligence in Medicine Market Analysis and Forecasts, 2019 – 2027

12.1. Overview

12.1.1. North America Artificial Intelligence in Medicine Market Revenue (US$ Mn)

12.2. North America Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

12.2.1. Hardware

12.2.2. Software

12.2.3. Service

12.3. North America Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

12.3.1. Querying Method

12.3.2. Natural Language Processing

12.3.3. Context Aware Processing

12.3.4. Speech Recognition

12.3.5. Decision Management

12.3.6. Others (Biometrics, AI Modeling, Etc.)

12.4. North America Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

12.4.1. Robot Assisted Surgery

12.4.2. Virtual Nursing Assistants

12.4.3. Administrative Workflow Assistance

12.4.4. Fraud Detection

12.4.5. Connected Machines

12.4.6. Clinical Trial

12.4.7. Preliminary Diagnosis

12.4.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)

12.5. North America Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

12.5.1. Healthcare Providers

12.5.2. Pharmaceutical & Biotechnology Company

12.5.3.  Patient

12.5.4. Payer

12.6. North America Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Country

12.6.1. U.S.

12.6.1.1.  U.S. Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

12.6.1.1.1.  Hardware

12.6.1.1.2.  Software

12.6.1.1.3.  Service

12.6.1.2.  U.S. Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

12.6.1.2.1.  Querying Method

12.6.1.2.2.  Natural Language Processing

12.6.1.2.3.  Context Aware Processing

12.6.1.2.4.  Speech Recognition

12.6.1.2.5.  Decision Management

12.6.1.2.6.  Others (Biometrics, AI Modeling, Etc.)

12.6.1.3.  U.S. Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

12.6.1.3.1.  Robot Assisted Surgery

12.6.1.3.2.  Virtual Nursing Assistants

12.6.1.3.3.  Administrative Workflow Assistance

12.6.1.3.4.  Fraud Detection

12.6.1.3.5.  Connected Machines

12.6.1.3.6.  Clinical Trial

12.6.1.3.7.  Preliminary Diagnosis

12.6.1.3.8.  Others (Dosage Error Reduction, Cybersecurity, Etc.)

12.6.1.4.  U.S. Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

12.6.1.4.1.  Healthcare Providers

12.6.1.4.2.  Pharmaceutical & Biotechnology Company

12.6.1.4.3.   Patient

12.6.1.4.4.  Payer

12.6.2. Canada

12.6.2.1.  Canada Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

12.6.2.1.1.  Hardware

12.6.2.1.2.  Software

12.6.2.1.3.  Service

12.6.2.2.  Canada Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

12.6.2.2.1.  Querying Method

12.6.2.2.2.  Natural Language Processing

12.6.2.2.3.  Context Aware Processing

12.6.2.2.4.  Speech Recognition

12.6.2.2.5.  Decision Management

12.6.2.2.6.  Others (Biometrics, AI Modeling, Etc.)

12.6.2.3.  Canada Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

12.6.2.3.1.  Robot Assisted Surgery

12.6.2.3.2.  Virtual Nursing Assistants

12.6.2.3.3.  Administrative Workflow Assistance

12.6.2.3.4.  Fraud Detection

12.6.2.3.5.  Connected Machines

12.6.2.3.6.  Clinical Trial

12.6.2.3.7.  Preliminary Diagnosis

12.6.2.3.8.  Others (Dosage Error Reduction, Cybersecurity, Etc.)

12.6.2.4.  Canada Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

12.6.2.4.1.  Healthcare Providers

12.6.2.4.2.  Pharmaceutical & Biotechnology Company

12.6.2.4.3.   Patient

12.6.2.4.4.  Payer

12.6.3. Mexico

12.6.3.1.  Mexico Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

12.6.3.1.1.  Hardware

12.6.3.1.2.  Software

12.6.3.1.3.  Service

12.6.3.2.  Mexico Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

12.6.3.2.1.  Querying Method

12.6.3.2.2.  Natural Language Processing

12.6.3.2.3.  Context Aware Processing

12.6.3.2.4.  Speech Recognition

12.6.3.2.5.  Decision Management

12.6.3.2.6.  Others (Biometrics, AI Modeling, Etc.)

12.6.3.3.  Mexico Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

12.6.3.3.1.  Robot Assisted Surgery

12.6.3.3.2.  Virtual Nursing Assistants

12.6.3.3.3.  Administrative Workflow Assistance

12.6.3.3.4.  Fraud Detection

12.6.3.3.5.  Connected Machines

12.6.3.3.6.  Clinical Trial

12.6.3.3.7.  Preliminary Diagnosis

12.6.3.3.8.  Others (Dosage Error Reduction, Cybersecurity, Etc.)

12.6.3.4.  Mexico Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

12.6.3.4.1.  Healthcare Providers

12.6.3.4.2.  Pharmaceutical & Biotechnology Company

12.6.3.4.3.   Patient

12.6.3.4.4.  Payer

12.6.4. Rest of North America

12.6.4.1.  Rest of North America Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

12.6.4.1.1.  Hardware

12.6.4.1.2.  Software

12.6.4.1.3.  Service

12.6.4.2.  Rest of North America Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

12.6.4.2.1.  Querying Method

12.6.4.2.2.  Natural Language Processing

12.6.4.2.3.  Context Aware Processing

12.6.4.2.4.  Speech Recognition

12.6.4.2.5.  Decision Management

12.6.4.2.6.  Others (Biometrics, AI Modeling, Etc.)

12.6.4.3.  Rest of North America Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

12.6.4.3.1.  Robot Assisted Surgery

12.6.4.3.2.  Virtual Nursing Assistants

12.6.4.3.3.  Administrative Workflow Assistance

12.6.4.3.4.  Fraud Detection

12.6.4.3.5.  Connected Machines

12.6.4.3.6.  Clinical Trial

12.6.4.3.7.  Preliminary Diagnosis

12.6.4.3.8.  Others (Dosage Error Reduction, Cybersecurity, Etc.)

12.6.4.4.  Rest of North America Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

12.6.4.4.1.  Healthcare Providers

12.6.4.4.2.  Pharmaceutical & Biotechnology Company

12.6.4.4.3.   Patient

12.6.4.4.4.  Payer

12.7. Key Segment for Channeling Investments

12.7.1. By Country

12.7.2. By Component

12.7.3. By Technology

12.7.4. By Application

12.7.5. By End Users

13. Europe Artificial Intelligence in Medicine Market Analysis and Forecasts, 2019 – 2027

13.1. Overview

13.1.1. Europe Artificial Intelligence in Medicine Market Revenue (US$ Mn)

13.2. Europe Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

13.2.1. Hardware

13.2.2. Software

13.2.3. Service

13.3. Europe Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

13.3.1. Querying Method

13.3.2. Natural Language Processing

13.3.3. Context Aware Processing

13.3.4. Speech Recognition

13.3.5. Decision Management

13.3.6. Others (Biometrics, AI Modeling, Etc.)

13.4. Europe Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

13.4.1. Robot Assisted Surgery

13.4.2. Virtual Nursing Assistants

13.4.3. Administrative Workflow Assistance

13.4.4. Fraud Detection

13.4.5. Connected Machines

13.4.6. Clinical Trial

13.4.7. Preliminary Diagnosis

13.4.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)

13.5. Europe Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

13.5.1. Healthcare Providers

13.5.2. Pharmaceutical & Biotechnology Company

13.5.3.  Patient

13.5.4. Payer

13.6. Europe Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Country

13.6.1. France

13.6.1.1.  France Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

13.6.1.1.1.  Hardware

13.6.1.1.2.  Software

13.6.1.1.3.  Service

13.6.1.2.  France Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

13.6.1.2.1.  Querying Method

13.6.1.2.2.  Natural Language Processing

13.6.1.2.3.  Context Aware Processing

13.6.1.2.4.  Speech Recognition

13.6.1.2.5.  Decision Management

13.6.1.2.6.  Others (Biometrics, AI Modeling, Etc.)

13.6.1.3.  France Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

13.6.1.3.1.  Robot Assisted Surgery

13.6.1.3.2.  Virtual Nursing Assistants

13.6.1.3.3.  Administrative Workflow Assistance

13.6.1.3.4.  Fraud Detection

13.6.1.3.5.  Connected Machines

13.6.1.3.6.  Clinical Trial

13.6.1.3.7.  Preliminary Diagnosis

13.6.1.3.8.  Others (Dosage Error Reduction, Cybersecurity, Etc.)

13.6.1.4.  France Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

13.6.1.4.1.  Healthcare Providers

13.6.1.4.2.  Pharmaceutical & Biotechnology Company

13.6.1.4.3.   Patient

13.6.1.4.4.  Payer

13.6.2. The UK

13.6.2.1.  The UK Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

13.6.2.1.1.  Hardware

13.6.2.1.2.  Software

13.6.2.1.3.  Service

13.6.2.2.  The UK Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

13.6.2.2.1.  Querying Method

13.6.2.2.2.  Natural Language Processing

13.6.2.2.3.  Context Aware Processing

13.6.2.2.4.  Speech Recognition

13.6.2.2.5.  Decision Management

13.6.2.2.6.  Others (Biometrics, AI Modeling, Etc.)

13.6.2.3.  The UK Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

13.6.2.3.1.  Robot Assisted Surgery

13.6.2.3.2.  Virtual Nursing Assistants

13.6.2.3.3.  Administrative Workflow Assistance

13.6.2.3.4.  Fraud Detection

13.6.2.3.5.  Connected Machines

13.6.2.3.6.  Clinical Trial

13.6.2.3.7.  Preliminary Diagnosis

13.6.2.3.8.  Others (Dosage Error Reduction, Cybersecurity, Etc.)

13.6.2.4.  The UK Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

13.6.2.4.1.  Healthcare Providers

13.6.2.4.2.  Pharmaceutical & Biotechnology Company

13.6.2.4.3.   Patient

13.6.2.4.4.  Payer

13.6.3. Spain

13.6.3.1.  Spain Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

13.6.3.1.1.  Hardware

13.6.3.1.2.  Software

13.6.3.1.3.  Service

13.6.3.2.  Spain Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

13.6.3.2.1.  Querying Method

13.6.3.2.2.  Natural Language Processing

13.6.3.2.3.  Context Aware Processing

13.6.3.2.4.  Speech Recognition

13.6.3.2.5.  Decision Management

13.6.3.2.6.  Others (Biometrics, AI Modeling, Etc.)

13.6.3.3.  Spain Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

13.6.3.3.1.  Robot Assisted Surgery

13.6.3.3.2.  Virtual Nursing Assistants

13.6.3.3.3.  Administrative Workflow Assistance

13.6.3.3.4.  Fraud Detection

13.6.3.3.5.  Connected Machines

13.6.3.3.6.  Clinical Trial

13.6.3.3.7.  Preliminary Diagnosis

13.6.3.3.8.  Others (Dosage Error Reduction, Cybersecurity, Etc.)

13.6.3.4.  Spain Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

13.6.3.4.1.  Healthcare Providers

13.6.3.4.2.  Pharmaceutical & Biotechnology Company

13.6.3.4.3.   Patient

13.6.3.4.4.  Payer

13.6.4. Germany

13.6.4.1.  Germany Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

13.6.4.1.1.  Hardware

13.6.4.1.2.  Software

13.6.4.1.3.  Service

13.6.4.2.  Germany Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

13.6.4.2.1.  Querying Method

13.6.4.2.2.  Natural Language Processing

13.6.4.2.3.  Context Aware Processing

13.6.4.2.4.  Speech Recognition

13.6.4.2.5.  Decision Management

13.6.4.2.6.  Others (Biometrics, AI Modeling, Etc.)

13.6.4.3.  Germany Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

13.6.4.3.1.  Robot Assisted Surgery

13.6.4.3.2.  Virtual Nursing Assistants

13.6.4.3.3.  Administrative Workflow Assistance

13.6.4.3.4.  Fraud Detection

13.6.4.3.5.  Connected Machines

13.6.4.3.6.  Clinical Trial

13.6.4.3.7.  Preliminary Diagnosis

13.6.4.3.8.  Others (Dosage Error Reduction, Cybersecurity, Etc.)

13.6.4.4.  Germany Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

13.6.4.4.1.  Healthcare Providers

13.6.4.4.2.  Pharmaceutical & Biotechnology Company

13.6.4.4.3.   Patient

13.6.4.4.4.  Payer

13.6.5. Italy

13.6.5.1.  Italy Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

13.6.5.1.1.  Hardware

13.6.5.1.2.  Software

13.6.5.1.3.  Service

13.6.5.2.  Italy Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

13.6.5.2.1.  Querying Method

13.6.5.2.2.  Natural Language Processing

13.6.5.2.3.  Context Aware Processing

13.6.5.2.4.  Speech Recognition

13.6.5.2.5.  Decision Management

13.6.5.2.6.  Others (Biometrics, AI Modeling, Etc.)

13.6.5.3.  Italy Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

13.6.5.3.1.  Robot Assisted Surgery

13.6.5.3.2.  Virtual Nursing Assistants

13.6.5.3.3.  Administrative Workflow Assistance

13.6.5.3.4.  Fraud Detection

13.6.5.3.5.  Connected Machines

13.6.5.3.6.  Clinical Trial

13.6.5.3.7.  Preliminary Diagnosis

13.6.5.3.8.  Others (Dosage Error Reduction, Cybersecurity, Etc.)

13.6.5.4.  Italy Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

13.6.5.4.1.  Healthcare Providers

13.6.5.4.2.  Pharmaceutical & Biotechnology Company

13.6.5.4.3.   Patient

13.6.5.4.4.  Payer

13.6.6. Nordic

13.6.6.1.  Nordic Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

13.6.6.1.1.  Hardware

13.6.6.1.2.  Software

13.6.6.1.3.  Service

13.6.6.2.  Nordic Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

13.6.6.2.1.  Querying Method

13.6.6.2.2.  Natural Language Processing

13.6.6.2.3.  Context Aware Processing

13.6.6.2.4.  Speech Recognition

13.6.6.2.5.  Decision Management

13.6.6.2.6.  Others (Biometrics, AI Modeling, Etc.)

13.6.6.3.  Nordic Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

13.6.6.3.1.  Robot Assisted Surgery

13.6.6.3.2.  Virtual Nursing Assistants

13.6.6.3.3.  Administrative Workflow Assistance

13.6.6.3.4.  Fraud Detection

13.6.6.3.5.  Connected Machines

13.6.6.3.6.  Clinical Trial

13.6.6.3.7.  Preliminary Diagnosis

13.6.6.3.8.  Others (Dosage Error Reduction, Cybersecurity, Etc.)

13.6.6.4.  Nordic Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

13.6.6.4.1.  Healthcare Providers

13.6.6.4.2.  Pharmaceutical & Biotechnology Company

13.6.6.4.3.   Patient

13.6.6.4.4.  Payer

13.6.6.5.  Nordic Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Country

13.6.6.5.1.  Sweden

13.6.6.5.2.  Norway

13.6.6.5.3.  Finland

13.6.6.5.4.  Denmark

13.6.6.5.5.  Iceland

13.6.6.5.6.  Rest of Nordic

13.6.7. The Benelux Union

13.6.7.1.  The Benelux Union Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

13.6.7.1.1.  Hardware

13.6.7.1.2.  Software

13.6.7.1.3.  Service

13.6.7.2.  The Benelux Union Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

13.6.7.2.1.  Querying Method

13.6.7.2.2.  Natural Language Processing

13.6.7.2.3.  Context Aware Processing

13.6.7.2.4.  Speech Recognition

13.6.7.2.5.  Decision Management

13.6.7.2.6.  Others (Biometrics, AI Modeling, Etc.)

13.6.7.3.  The Benelux Union Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

13.6.7.3.1.  Robot Assisted Surgery

13.6.7.3.2.  Virtual Nursing Assistants

13.6.7.3.3.  Administrative Workflow Assistance

13.6.7.3.4.  Fraud Detection

13.6.7.3.5.  Connected Machines

13.6.7.3.6.  Clinical Trial

13.6.7.3.7.  Preliminary Diagnosis

13.6.7.3.8.  Others (Dosage Error Reduction, Cybersecurity, Etc.)

13.6.7.4.  The Benelux Union Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

13.6.7.4.1.  Healthcare Providers

13.6.7.4.2.  Pharmaceutical & Biotechnology Company

13.6.7.4.3.   Patient

13.6.7.4.4.  Payer

13.6.7.5.  The Benelux Union Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Country

13.6.7.5.1.  Belgium

13.6.7.5.2.  Netherlands

13.6.7.5.3.  Luxembourg

13.6.8. Rest of Europe

13.6.8.1.  Rest of Europe Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

13.6.8.1.1.  Hardware

13.6.8.1.2.  Software

13.6.8.1.3.  Service

13.6.8.2.  Rest of Europe Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

13.6.8.2.1.  Querying Method

13.6.8.2.2.  Natural Language Processing

13.6.8.2.3.  Context Aware Processing

13.6.8.2.4.  Speech Recognition

13.6.8.2.5.  Decision Management

13.6.8.2.6.  Others (Biometrics, AI Modeling, Etc.)

13.6.8.3.  Rest of Europe Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

13.6.8.3.1.  Robot Assisted Surgery

13.6.8.3.2.  Virtual Nursing Assistants

13.6.8.3.3.  Administrative Workflow Assistance

13.6.8.3.4.  Fraud Detection

13.6.8.3.5.  Connected Machines

13.6.8.3.6.  Clinical Trial

13.6.8.3.7.  Preliminary Diagnosis

13.6.8.3.8.  Others (Dosage Error Reduction, Cybersecurity, Etc.)

13.6.8.4.  Rest of Europe Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

13.6.8.4.1.  Healthcare Providers

13.6.8.4.2.  Pharmaceutical & Biotechnology Company

13.6.8.4.3.   Patient

13.6.8.4.4.  Payer

13.7. Key Segment for Channeling Investments

13.7.1. By Country

13.7.2. By Component

13.7.3. By Technology

13.7.4. By Application

13.7.5. By End Users

14. Asia Pacific Artificial Intelligence in Medicine Market Analysis and Forecasts, 2019 – 2027

14.1. Overview

14.1.1. Asia Pacific Artificial Intelligence in Medicine Market Revenue (US$ Mn)

14.2. Asia Pacific Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

14.2.1. Hardware

14.2.2. Software

14.2.3. Service

14.3. Asia Pacific Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

14.3.1. Querying Method

14.3.2. Natural Language Processing

14.3.3. Context Aware Processing

14.3.4. Speech Recognition

14.3.5. Decision Management

14.3.6. Others (Biometrics, AI Modeling, Etc.)

14.4. Asia Pacific Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

14.4.1. Robot Assisted Surgery

14.4.2. Virtual Nursing Assistants

14.4.3. Administrative Workflow Assistance

14.4.4. Fraud Detection

14.4.5. Connected Machines

14.4.6. Clinical Trial

14.4.7. Preliminary Diagnosis

14.4.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)

14.5. Asia Pacific Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

14.5.1. Healthcare Providers

14.5.2. Pharmaceutical & Biotechnology Company

14.5.3.  Patient

14.5.4. Payer

14.6. Asia Pacific Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Country

14.6.1. China

14.6.1.1.  China Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

14.6.1.1.1.  Hardware

14.6.1.1.2.  Software

14.6.1.1.3.  Service

14.6.1.2.  China Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

14.6.1.2.1.  Querying Method

14.6.1.2.2.  Natural Language Processing

14.6.1.2.3.  Context Aware Processing

14.6.1.2.4.  Speech Recognition

14.6.1.2.5.  Decision Management

14.6.1.2.6.  Others (Biometrics, AI Modeling, Etc.)

14.6.1.3.  China Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

14.6.1.3.1.  Robot Assisted Surgery

14.6.1.3.2.  Virtual Nursing Assistants

14.6.1.3.3.  Administrative Workflow Assistance

14.6.1.3.4.  Fraud Detection

14.6.1.3.5.  Connected Machines

14.6.1.3.6.  Clinical Trial

14.6.1.3.7.  Preliminary Diagnosis

14.6.1.3.8.  Others (Dosage Error Reduction, Cybersecurity, Etc.)

14.6.1.4.  China Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

14.6.1.4.1.  Healthcare Providers

14.6.1.4.2.  Pharmaceutical & Biotechnology Company

14.6.1.4.3.   Patient

14.6.1.4.4.  Payer

14.6.2. Japan

14.6.2.1.  Japan Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

14.6.2.1.1.  Hardware

14.6.2.1.2.  Software

14.6.2.1.3.  Service

14.6.2.2.  Japan Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

14.6.2.2.1.  Querying Method

14.6.2.2.2.  Natural Language Processing

14.6.2.2.3.  Context Aware Processing

14.6.2.2.4.  Speech Recognition

14.6.2.2.5.  Decision Management

14.6.2.2.6.  Others (Biometrics, AI Modeling, Etc.)

14.6.2.3.  Japan Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

14.6.2.3.1.  Robot Assisted Surgery

14.6.2.3.2.  Virtual Nursing Assistants

14.6.2.3.3.  Administrative Workflow Assistance

14.6.2.3.4.  Fraud Detection

14.6.2.3.5.  Connected Machines

14.6.2.3.6.  Clinical Trial

14.6.2.3.7.  Preliminary Diagnosis

14.6.2.3.8.  Others (Dosage Error Reduction, Cybersecurity, Etc.)

14.6.2.4.  Japan Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

14.6.2.4.1.  Healthcare Providers

14.6.2.4.2.  Pharmaceutical & Biotechnology Company

14.6.2.4.3.   Patient

14.6.2.4.4.  Payer

14.6.3. India

14.6.3.1.  India Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

14.6.3.1.1.  Hardware

14.6.3.1.2.  Software

14.6.3.1.3.  Service

14.6.3.2.  India Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

14.6.3.2.1.  Querying Method

14.6.3.2.2.  Natural Language Processing

14.6.3.2.3.  Context Aware Processing

14.6.3.2.4.  Speech Recognition

14.6.3.2.5.  Decision Management

14.6.3.2.6.  Others (Biometrics, AI Modeling, Etc.)

14.6.3.3.  India Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

14.6.3.3.1.  Robot Assisted Surgery

14.6.3.3.2.  Virtual Nursing Assistants

14.6.3.3.3.  Administrative Workflow Assistance

14.6.3.3.4.  Fraud Detection

14.6.3.3.5.  Connected Machines

14.6.3.3.6.  Clinical Trial

14.6.3.3.7.  Preliminary Diagnosis

14.6.3.3.8.  Others (Dosage Error Reduction, Cybersecurity, Etc.)

14.6.3.4.  India Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

14.6.3.4.1.  Healthcare Providers

14.6.3.4.2.  Pharmaceutical & Biotechnology Company

14.6.3.4.3.   Patient

14.6.3.4.4.  Payer

14.6.4. Australia

14.6.4.1.  Australia Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

14.6.4.1.1.  Hardware

14.6.4.1.2.  Software

14.6.4.1.3.  Service

14.6.4.2.  Australia Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

14.6.4.2.1.  Querying Method

14.6.4.2.2.  Natural Language Processing

14.6.4.2.3.  Context Aware Processing

14.6.4.2.4.  Speech Recognition

14.6.4.2.5.  Decision Management

14.6.4.2.6.  Others (Biometrics, AI Modeling, Etc.)

14.6.4.3.  Australia Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

14.6.4.3.1.  Robot Assisted Surgery

14.6.4.3.2.  Virtual Nursing Assistants

14.6.4.3.3.  Administrative Workflow Assistance

14.6.4.3.4.  Fraud Detection

14.6.4.3.5.  Connected Machines

14.6.4.3.6.  Clinical Trial

14.6.4.3.7.  Preliminary Diagnosis

14.6.4.3.8.  Others (Dosage Error Reduction, Cybersecurity, Etc.)

14.6.4.4.  Australia Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

14.6.4.4.1.  Healthcare Providers

14.6.4.4.2.  Pharmaceutical & Biotechnology Company

14.6.4.4.3.   Patient

14.6.4.4.4.  Payer

14.6.5. New Zealand

14.6.5.1.  New Zealand Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

14.6.5.1.1.  Hardware

14.6.5.1.2.  Software

14.6.5.1.3.  Service

14.6.5.2.  New Zealand Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

14.6.5.2.1.  Querying Method

14.6.5.2.2.  Natural Language Processing

14.6.5.2.3.  Context Aware Processing

14.6.5.2.4.  Speech Recognition

14.6.5.2.5.  Decision Management

14.6.5.2.6.  Others (Biometrics, AI Modeling, Etc.)

14.6.5.3.  New Zealand Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

14.6.5.3.1.  Robot Assisted Surgery

14.6.5.3.2.  Virtual Nursing Assistants

14.6.5.3.3.  Administrative Workflow Assistance

14.6.5.3.4.  Fraud Detection

14.6.5.3.5.  Connected Machines

14.6.5.3.6.  Clinical Trial

14.6.5.3.7.  Preliminary Diagnosis

14.6.5.3.8.  Others (Dosage Error Reduction, Cybersecurity, Etc.)

14.6.5.4.  New Zealand Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

14.6.5.4.1.  Healthcare Providers

14.6.5.4.2.  Pharmaceutical & Biotechnology Company

14.6.5.4.3.   Patient

14.6.5.4.4.  Payer

14.6.6. Southeast Asia

14.6.6.1.  Southeast Asia Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

14.6.6.1.1.  Hardware

14.6.6.1.2.  Software

14.6.6.1.3.  Service

14.6.6.2.  Southeast Asia Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

14.6.6.2.1.  Querying Method

14.6.6.2.2.  Natural Language Processing

14.6.6.2.3.  Context Aware Processing

14.6.6.2.4.  Speech Recognition

14.6.6.2.5.  Decision Management

14.6.6.2.6.  Others (Biometrics, AI Modeling, Etc.)

14.6.6.3.  Southeast Asia Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

14.6.6.3.1.  Robot Assisted Surgery

14.6.6.3.2.  Virtual Nursing Assistants

14.6.6.3.3.  Administrative Workflow Assistance

14.6.6.3.4.  Fraud Detection

14.6.6.3.5.  Connected Machines

14.6.6.3.6.  Clinical Trial

14.6.6.3.7.  Preliminary Diagnosis

14.6.6.3.8.  Others (Dosage Error Reduction, Cybersecurity, Etc.)

14.6.6.4.  Southeast Asia Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

14.6.6.4.1.  Healthcare Providers

14.6.6.4.2.  Pharmaceutical & Biotechnology Company

14.6.6.4.3.   Patient

14.6.6.4.4.  Payer

14.6.7. Rest of Asia Pacific

14.6.7.1.  Rest of Asia Pacific Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

14.6.7.1.1.  Hardware

14.6.7.1.2.  Software

14.6.7.1.3.  Service

14.6.7.2.  Rest of Asia Pacific Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

14.6.7.2.1.  Querying Method

14.6.7.2.2.  Natural Language Processing

14.6.7.2.3.  Context Aware Processing

14.6.7.2.4.  Speech Recognition

14.6.7.2.5.  Decision Management

14.6.7.2.6.  Others (Biometrics, AI Modeling, Etc.)

14.6.7.3.  Rest of Asia Pacific Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

14.6.7.3.1.  Robot Assisted Surgery

14.6.7.3.2.  Virtual Nursing Assistants

14.6.7.3.3.  Administrative Workflow Assistance

14.6.7.3.4.  Fraud Detection

14.6.7.3.5.  Connected Machines

14.6.7.3.6.  Clinical Trial

14.6.7.3.7.  Preliminary Diagnosis

14.6.7.3.8.  Others (Dosage Error Reduction, Cybersecurity, Etc.)

14.6.7.4.  Rest of Asia Pacific Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

14.6.7.4.1.  Healthcare Providers

14.6.7.4.2.  Pharmaceutical & Biotechnology Company

14.6.7.4.3.   Patient

14.6.7.4.4.  Payer

14.7. Key Segment for Channeling Investments

14.7.1. By Country

14.7.2. By Component

14.7.3. By Technology

14.7.4. By Application

14.7.5. By End Users

15. Middle East and Africa Artificial Intelligence in Medicine Market Analysis and Forecasts, 2019 – 2027

15.1. Overview

15.1.1. Middle East and Africa Artificial Intelligence in Medicine Market Revenue (US$ Mn)

15.2. Middle East and Africa Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

15.2.1. Hardware

15.2.2. Software

15.2.3. Service

15.3. Middle East and Africa Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

15.3.1. Querying Method

15.3.2. Natural Language Processing

15.3.3. Context Aware Processing

15.3.4. Speech Recognition

15.3.5. Decision Management

15.3.6. Others (Biometrics, AI Modeling, Etc.)

15.4. Middle East and Africa Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

15.4.1. Robot Assisted Surgery

15.4.2. Virtual Nursing Assistants

15.4.3. Administrative Workflow Assistance

15.4.4. Fraud Detection

15.4.5. Connected Machines

15.4.6. Clinical Trial

15.4.7. Preliminary Diagnosis

15.4.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)

15.5. Middle East and Africa Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

15.5.1. Healthcare Providers

15.5.2. Pharmaceutical & Biotechnology Company

15.5.3.  Patient

15.5.4. Payer

15.6. Middle East and Africa Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Country

15.6.1. GCC Countries

15.6.1.1.  GCC Countries Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

15.6.1.1.1.  Hardware

15.6.1.1.2.  Software

15.6.1.1.3.  Service

15.6.1.2.  GCC Countries Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

15.6.1.2.1.  Querying Method

15.6.1.2.2.  Natural Language Processing

15.6.1.2.3.  Context Aware Processing

15.6.1.2.4.  Speech Recognition

15.6.1.2.5.  Decision Management

15.6.1.2.6.  Others (Biometrics, AI Modeling, Etc.)

15.6.1.3.  GCC Countries Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

15.6.1.3.1.  Robot Assisted Surgery

15.6.1.3.2.  Virtual Nursing Assistants

15.6.1.3.3.  Administrative Workflow Assistance

15.6.1.3.4.  Fraud Detection

15.6.1.3.5.  Connected Machines

15.6.1.3.6.  Clinical Trial

15.6.1.3.7.  Preliminary Diagnosis

15.6.1.3.8.  Others (Dosage Error Reduction, Cybersecurity, Etc.)

15.6.1.4.  GCC Countries Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

15.6.1.4.1.  Healthcare Providers

15.6.1.4.2.  Pharmaceutical & Biotechnology Company

15.6.1.4.3.   Patient

15.6.1.4.4.  Payer

15.6.2. Southern Africa

15.6.2.1.  Southern Africa Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

15.6.2.1.1.  Hardware

15.6.2.1.2.  Software

15.6.2.1.3.  Service

15.6.2.2.  Southern Africa Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

15.6.2.2.1.  Querying Method

15.6.2.2.2.  Natural Language Processing

15.6.2.2.3.  Context Aware Processing

15.6.2.2.4.  Speech Recognition

15.6.2.2.5.  Decision Management

15.6.2.2.6.  Others (Biometrics, AI Modeling, Etc.)

15.6.2.3.  Southern Africa Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

15.6.2.3.1.  Robot Assisted Surgery

15.6.2.3.2.  Virtual Nursing Assistants

15.6.2.3.3.  Administrative Workflow Assistance

15.6.2.3.4.  Fraud Detection

15.6.2.3.5.  Connected Machines

15.6.2.3.6.  Clinical Trial

15.6.2.3.7.  Preliminary Diagnosis

15.6.2.3.8.  Others (Dosage Error Reduction, Cybersecurity, Etc.)

15.6.2.4.  Southern Africa Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

15.6.2.4.1.  Healthcare Providers

15.6.2.4.2.  Pharmaceutical & Biotechnology Company

15.6.2.4.3.   Patient

15.6.2.4.4.  Payer

15.6.3. Rest of MEA

15.6.3.1.  Rest of MEA Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

15.6.3.1.1.  Hardware

15.6.3.1.2.  Software

15.6.3.1.3.  Service

15.6.3.2.  Rest of MEA Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

15.6.3.2.1.  Querying Method

15.6.3.2.2.  Natural Language Processing

15.6.3.2.3.  Context Aware Processing

15.6.3.2.4.  Speech Recognition

15.6.3.2.5.  Decision Management

15.6.3.2.6.  Others (Biometrics, AI Modeling, Etc.)

15.6.3.3.  Rest of MEA Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

15.6.3.3.1.  Robot Assisted Surgery

15.6.3.3.2.  Virtual Nursing Assistants

15.6.3.3.3.  Administrative Workflow Assistance

15.6.3.3.4.  Fraud Detection

15.6.3.3.5.  Connected Machines

15.6.3.3.6.  Clinical Trial

15.6.3.3.7.  Preliminary Diagnosis

15.6.3.3.8.  Others (Dosage Error Reduction, Cybersecurity, Etc.)

15.6.3.4.  Rest of MEA Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

15.6.3.4.1.  Healthcare Providers

15.6.3.4.2.  Pharmaceutical & Biotechnology Company

15.6.3.4.3.   Patient

15.6.3.4.4.  Payer

15.7. Key Segment for Channeling Investments

15.7.1. By Country

15.7.2. By Component

15.7.3. By Technology

15.7.4. By Application

15.7.5. By End Users

16. Latin America Artificial Intelligence in Medicine Market Analysis and Forecasts, 2019 – 2027

16.1. Overview

16.1.1. Latin America Artificial Intelligence in Medicine Market Revenue (US$ Mn)

16.2. Latin America Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

16.2.1. Hardware

16.2.2. Software

16.2.3. Service

16.3. Latin America Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

16.3.1. Querying Method

16.3.2. Natural Language Processing

16.3.3. Context Aware Processing

16.3.4. Speech Recognition

16.3.5. Decision Management

16.3.6. Others (Biometrics, AI Modeling, Etc.)

16.4. Latin America Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

16.4.1. Robot Assisted Surgery

16.4.2. Virtual Nursing Assistants

16.4.3. Administrative Workflow Assistance

16.4.4. Fraud Detection

16.4.5. Connected Machines

16.4.6. Clinical Trial

16.4.7. Preliminary Diagnosis

16.4.8. Others (Dosage Error Reduction, Cybersecurity, Etc.)

16.5. Latin America Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

16.5.1. Healthcare Providers

16.5.2. Pharmaceutical & Biotechnology Company

16.5.3.  Patient

16.5.4. Payer

16.6. Latin America Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Country

16.6.1. Brazil

16.6.1.1.  Brazil Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

16.6.1.1.1.  Hardware

16.6.1.1.2.  Software

16.6.1.1.3.  Service

16.6.1.2.  Brazil Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

16.6.1.2.1.  Querying Method

16.6.1.2.2.  Natural Language Processing

16.6.1.2.3.  Context Aware Processing

16.6.1.2.4.  Speech Recognition

16.6.1.2.5.  Decision Management

16.6.1.2.6.  Others (Biometrics, AI Modeling, Etc.)

16.6.1.3.  Brazil Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

16.6.1.3.1.  Robot Assisted Surgery

16.6.1.3.2.  Virtual Nursing Assistants

16.6.1.3.3.  Administrative Workflow Assistance

16.6.1.3.4.  Fraud Detection

16.6.1.3.5.  Connected Machines

16.6.1.3.6.  Clinical Trial

16.6.1.3.7.  Preliminary Diagnosis

16.6.1.3.8.  Others (Dosage Error Reduction, Cybersecurity, Etc.)

16.6.1.4.  Brazil Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

16.6.1.4.1.  Healthcare Providers

16.6.1.4.2.  Pharmaceutical & Biotechnology Company

16.6.1.4.3.   Patient

16.6.1.4.4.  Payer

16.6.2. Argentina

16.6.2.1.  Argentina Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

16.6.2.1.1.  Hardware

16.6.2.1.2.  Software

16.6.2.1.3.  Service

16.6.2.2.  Argentina Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

16.6.2.2.1.  Querying Method

16.6.2.2.2.  Natural Language Processing

16.6.2.2.3.  Context Aware Processing

16.6.2.2.4.  Speech Recognition

16.6.2.2.5.  Decision Management

16.6.2.2.6.  Others (Biometrics, AI Modeling, Etc.)

16.6.2.3.  Argentina Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

16.6.2.3.1.  Robot Assisted Surgery

16.6.2.3.2.  Virtual Nursing Assistants

16.6.2.3.3.  Administrative Workflow Assistance

16.6.2.3.4.  Fraud Detection

16.6.2.3.5.  Connected Machines

16.6.2.3.6.  Clinical Trial

16.6.2.3.7.  Preliminary Diagnosis

16.6.2.3.8.  Others (Dosage Error Reduction, Cybersecurity, Etc.)

16.6.2.4.  Argentina Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

16.6.2.4.1.  Healthcare Providers

16.6.2.4.2.  Pharmaceutical & Biotechnology Company

16.6.2.4.3.   Patient

16.6.2.4.4.  Payer

16.6.3. Rest of Latin America

16.6.3.1.  Rest of Latin America Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Component

16.6.3.1.1.  Hardware

16.6.3.1.2.  Software

16.6.3.1.3.  Service

16.6.3.2.  Rest of Latin America Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Technology

16.6.3.2.1.  Querying Method

16.6.3.2.2.  Natural Language Processing

16.6.3.2.3.  Context Aware Processing

16.6.3.2.4.  Speech Recognition

16.6.3.2.5.  Decision Management

16.6.3.2.6.  Others (Biometrics, AI Modeling, Etc.)

16.6.3.3.  Rest of Latin America Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By Application

16.6.3.3.1.  Robot Assisted Surgery

16.6.3.3.2.  Virtual Nursing Assistants

16.6.3.3.3.  Administrative Workflow Assistance

16.6.3.3.4.  Fraud Detection

16.6.3.3.5.  Connected Machines

16.6.3.3.6.  Clinical Trial

16.6.3.3.7.  Preliminary Diagnosis

16.6.3.3.8.  Others (Dosage Error Reduction, Cybersecurity, Etc.)

16.6.3.4.  Rest of Latin America Artificial Intelligence in Medicine Market Revenue (US$ Mn) and Forecasts, By End Users

16.6.3.4.1.  Healthcare Providers

16.6.3.4.2.  Pharmaceutical & Biotechnology Company

16.6.3.4.3.   Patient

16.6.3.4.4.  Payer

16.7. Key Segment for Channeling Investments

16.7.1. By Country

16.7.2. By Component

16.7.3. By Technology

16.7.4. By Application

16.7.5. By End Users

17. Competitive Benchmarking

17.1. Player Positioning Analysis

17.2. Global Presence and Growth Strategies

18. Player Profiles

18.1. Bay Labs, Inc

18.1.1. Company Details

18.1.2. Company Overview

18.1.3. Product Offerings

18.1.4. Key Developments

18.1.5. Financial Analysis

18.1.6. SWOT Analysis

18.1.7. Business Strategies

18.2. CloudMedx Inc.

18.2.1. Company Details

18.2.2. Company Overview

18.2.3. Product Offerings

18.2.4. Key Developments

18.2.5. Financial Analysis

18.2.6. SWOT Analysis

18.2.7. Business Strategies

18.3. Enclitic

18.3.1. Company Details

18.3.2. Company Overview

18.3.3. Product Offerings

18.3.4. Key Developments

18.3.5. Financial Analysis

18.3.6. SWOT Analysis

18.3.7. Business Strategies

18.4. General Electric

18.4.1. Company Details

18.4.2. Company Overview

18.4.3. Product Offerings

18.4.4. Key Developments

18.4.5. Financial Analysis

18.4.6. SWOT Analysis

18.4.7. Business Strategies

18.5. General Vision

18.5.1. Company Details

18.5.2. Company Overview

18.5.3. Product Offerings

18.5.4. Key Developments

18.5.5. Financial Analysis

18.5.6. SWOT Analysis

18.5.7. Business Strategies

18.6. Google Inc.

18.6.1. Company Details

18.6.2. Company Overview

18.6.3. Product Offerings

18.6.4. Key Developments

18.6.5. Financial Analysis

18.6.6. SWOT Analysis

18.6.7. Business Strategies

18.7. IBM Corporation

18.7.1. Company Details

18.7.2. Company Overview

18.7.3. Product Offerings

18.7.4. Key Developments

18.7.5. Financial Analysis

18.7.6. SWOT Analysis

18.7.7. Business Strategies

18.8. iCarbonX

18.8.1. Company Details

18.8.2. Company Overview

18.8.3. Product Offerings

18.8.4. Key Developments

18.8.5. Financial Analysis

18.8.6. SWOT Analysis

18.8.7. Business Strategies

18.9. Intel Corporation

18.9.1. Company Details

18.9.2. Company Overview

18.9.3. Product Offerings

18.9.4. Key Developments

18.9.5. Financial Analysis

18.9.6. SWOT Analysis

18.9.7. Business Strategies

18.10. Koninklijke Philips

18.10.1.  Company Details

18.10.2.  Company Overview

18.10.3.  Product Offerings

18.10.4.  Key Developments

18.10.5.  Financial Analysis

18.10.6.  SWOT Analysis

18.10.7.  Business Strategies

18.11. maxQ

18.11.1.  Company Details

18.11.2.  Company Overview

18.11.3.  Product Offerings

18.11.4.  Key Developments

18.11.5.  Financial Analysis

18.11.6.  SWOT Analysis

18.11.7.  Business Strategies

18.12. Microsoft

18.12.1.  Company Details

18.12.2.  Company Overview

18.12.3.  Product Offerings

18.12.4.  Key Developments

18.12.5.  Financial Analysis

18.12.6.  SWOT Analysis

18.12.7.  Business Strategies

18.13. Next IT Corp.

18.13.1.  Company Details

18.13.2.  Company Overview

18.13.3.  Product Offerings

18.13.4.  Key Developments

18.13.5.  Financial Analysis

18.13.6.  SWOT Analysis

18.13.7.  Business Strategies

18.14. Nvidia Corporation

18.14.1.  Company Details

18.14.2.  Company Overview

18.14.3.  Product Offerings

18.14.4.  Key Developments

18.14.5.  Financial Analysis

18.14.6.  SWOT Analysis

18.14.7.  Business Strategies

18.15. Siemens Healthcare GmbH

18.15.1.  Company Details

18.15.2.  Company Overview

18.15.3.  Product Offerings

18.15.4.  Key Developments

18.15.5.  Financial Analysis

18.15.6.  SWOT Analysis

18.15.7.  Business Strategies

18.16. Welltok

18.16.1.  Company Details

18.16.2.  Company Overview

18.16.3.  Product Offerings

18.16.4.  Key Developments

18.16.5.  Financial Analysis

18.16.6.  SWOT Analysis

18.16.7.  Business Strategies

19. Key Findings

 

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

 

**Exclusive for Multi-User and Enterprise User

 

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews  are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.  

Prominent participants in our primary research process include:

  • Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
  • Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

  • Reuters
  • Factiva
  • Bloomberg
  • One Source
  • Hoovers

Research Methodology

Methodology

Key Inclusions

Methodology

  • A PHP Error was encountered

    Severity: Notice

    Message: Undefined offset: 0

    Filename: pages/reportpage.php

    Line Number: 163

    Backtrace:

    File: /var/www/html/ami/application/views/pages/reportpage.php
    Line: 163
    Function: _error_handler

    File: /var/www/html/ami/application/controllers/Report.php
    Line: 153
    Function: view

    File: /var/www/html/ami/index.php
    Line: 315
    Function: require_once